Michael Ganio, PharmD, senior director, Pharmacy Practice and Quality, American Society of Health-System Pharmacists, reviews the recently released data on both the Novavax and Johnson…

Valerie Montgomery Rice, MD, FACOG, president and dean, Morehouse School of Medicine, discusses a video series that was recently created by the medical and health community for the medical and health community featuring physicians and nurses, including Dr Anthony Fauci. This video series was…

Donna Prosser, DNP, RN, FACHE, BCPA, Patient Safety Movement Foundation, discusses the rate of medical errors that occur every year worldwide, and highlights how the newly formed Patient Safety Movement Foundation will help address medical errors through its three critical model components, which…

Tom Kraus, vice president of government relations, ASHP, explains how policy makers at state levels have recognized that their health care workforce is sometimes strained, and highlights why these stakeholders turn to pharmacists to authorize them to provide additional services.

Karlee Paloukos, PharmD candidate, University of Utah College of Pharmacy, explains the risks of mailing prescriptions, which are likely to spend a substantial portion of time outside the recommended safe temperature range for most medications, and highlights why increased regulation of mail-order…

Tom Kraus, vice president of government relations, ASHP, discusses how reimbursement for pharmacists is impacted as a result of health plans waiving cost sharing for COVID-19 tests, and provides details on the costs linked with the new vaccines.

Michael Ganio, PharmD, senior director, pharmacy practice and quality, ASHP, discusses 2020 drug shortage trends, highlights how NDMA exposure can be improved during the manufacturing process, and provides a future prediction on how he sees pharmacy care changing based off of the challenges faced…

Tom Kraus, vice president of government relations, ASHP, discusses drug pricing trends seen over the past 12 months and highlights what is expected as 2021 approaches.

Anna Legreid Dopp, PharmD, senior director of clinical guidelines and quality improvement, ASHP, provides the need-to-know details of the COVID-19 vaccine, including how the vaccine rollout will impact the everyday work of a pharmacist as well as the associated challenges, and she stresses the…

Anna Dopp, PharmD, senior director of clinical guidelines and quality improvement, ASHP, discusses recent recommendations from the National Academies of Sciences, Engineering, and Medicine, and highlights how pharmacists have been prioritized to high-risk frontline health care workers, why a…